Investment Pitches

Pitch Summary:
Tenaris is a global leader in OCTG and premium steel pipe with a tightly integrated footprint (16 countries) and a fast-growing RigDirect model that now covers ~70% of global OCTG sales and ~90% in the U.S. The company’s automation (e.g., Bay City, TX) and proprietary grades/connections (≈75% of OCTG) underpin cost and mix advantages versus peers. After an 18–44% U.S. OCTG price correction in 2023–9M24, pricing inflected upward from September and imports rolled over, setting the stage for margin recovery even without a big rig rebound. Internationally, a strong offshore backlog into 2025–26 and normalizing Middle East demand support volumes. Argentina (10–15% of sales) adds upside via Vaca Muerta pipe orders (e.g., Vaca Muerta Sur) and anticipated rig/pipeline growth under Milei’s reforms. Potential U.S. protectionism, faster permitting, and tighter trade enforcement could further favor Tenaris’ U.S. operations and pricing. Balance sheet strength (≈$3.5B cash vs. ≈$0.5B debt) enables continued buybacks/dividends and optional M&A; a $700M repurchase runs through Mar-25 after a prior $1.2B program. Shares trade around a ~10% FCF yield and ~6× EBITDA, with room for positive estimate revisions as Pipe Logix indices firm. May 2025 AGM could introduce a more explicit capital returns framework (e.g., lifting 10% buyback cap). We see continued upside as earnings and FCF re-accelerate on pricing, mix (premium connections), and international backlog conversion.

BSD Analysis:
Tenaris makes seamless/welded OCTG, line pipe, coiled tubing, and premium connections, serving energy and industrial end markets via a global mill and service-center network. Set-up: After a two-year U.S. OCTG price slump and elevated imports, prices bottomed in late 2024 and have been rising; imports fell q/q in 3Q24 amid stricter enforcement, easing supply pressure. Differentiation: The RigDirect model simplifies customer supply chains (JIT delivery to ~530 rigs), improves working capital for customers, and increases Tenaris’ scheduling/asset utilization; high automation (8k+ sensors, 30+ robots at Bay City) cuts labor needs ~80% vs. legacy mills. Mix: Premium connections (gas-tight) and seamless share (≈80% of revenue) drive higher ASPs/margins; Tenaris’ proprietary portfolio and global qualification base are hard to replicate. Financials/Capital returns: Net cash position and double buyback cadence (>$1.9B across 2023–1Q25) support sustained FCF return while preserving M&A firepower. Risks: Slower OCTG price recovery, lumpy Middle East orders (Aramco inventory), Argentine macro execution, and cyclical U.S. onshore activity; Chinese/Korean supply responses remain a swing factor. View: A quality leader at a value multiple with catalysts from price/mix recovery, Argentina growth, and potential capital-return framework upgrades.

Pitch Summary:
Velan Inc. (TSX:VLN) is a global industrial valve manufacturer entering a catalyst-rich period following two transformational transactions. The company is selling its French business to Framatome for $200m and using proceeds to eliminate $150m of asbestos liabilities, unlocking $67m of net cash and removing a decades-Bull overhang. The asbestos settlements had cost ~$10m annually and limited M&A appeal; their removal makes Velan immediately more saleable. Flowserve’s 2023 bid valued Velan at ~$395m (including asbestos), or nearly 10× synergized EBITDA, compared to the current 90% of reactors globally) and LNG cryogenic products position it squarely in two multiyear capex upcycles. At 10× standalone EBITDA, the equity could be worth ~C$28 per share, implying >60% upside. The key near-term catalyst is a sale of the remaining company post-French divestiture and asbestos resolution.

BSD Analysis:
Velan designs and manufactures high-performance industrial valves for power generation, nuclear, LNG, petrochemical, and defense end-markets, with 12 plants across North America, Europe, and Asia. Set-up: After selling its French subsidiary and settling asbestos liabilities, Velan becomes a cash-rich, clean industrial asset previously constrained by family control and legal encumbrances. Differentiation: Exposure to nuclear reactor buildout (SMRs, refurbishments) and LNG infrastructure expansion provides multi-year secular demand visibility. Corporate dynamics: Governance has improved with an independent CEO and chairman replacing family leadership; the controlling Velan brothers likely seek an exit. Valuation: Currently trades under 5× EBITDA versus prior takeover at ~10×; removing contingent liabilities should attract strategic buyers (Flowserve, GEH, Westinghouse). Risks: Geopolitical barriers to U.S. buyers, trade tariffs, or family reluctance to sell could delay monetization; however, these are partly offset by strategic scarcity value in nuclear-grade valves. View: A clean, undervalued industrial prime for acquisition within 12 months—an asymmetric play on restructuring and M&A.

Pitch Summary:
Challenger Limited (CGF) is Australia’s dominant annuity provider with 80% market share and $26bn in life investment assets. Shares trade near 9× FY26E earnings—about a 25–30% discount to history—despite the potential for a structural uplift from APRA’s proposed capital changes. The new capital rules would better match asset–liability movements, freeing $400–700m of immediate capital and up to $1.5bn total (~30–35% of shares) for buybacks or reinvestment. Current regulation captures only one-third of credit spread offsets versus ~80% allowed under Solvency II, forcing Challenger to overcapitalize and occasionally issue equity during stress. APRA’s shift would normalize capital intensity (11% → ~6–7%) and stabilize PCA ratios during volatility. Management has already improved efficiency (cost-to-income 32%) and completed a tech re-platform that supports scalability. The company is expected to generate $440–480m normalized NPAT in FY25 with an 11% ROE. A capital release plus multiple re-rating to historical 11.5× could yield 21–26% two-year IRR or 48–58% upside over 12–18 months. Downside (~15%) stems mainly from delayed or diluted regulatory reform and spread-widening in credit markets. The setup offers a 2.7×–3.9× reward-to-risk skew with a near-term policy catalyst.

BSD Analysis:
Challenger underwrites fixed-term and lifetime annuities via its Life division and manages $121bn FUM. Set-up: Regulatory capital rules (LPS 112) have Bull constrained growth and forced dilutive raises, leaving the stock under-owned and trading at cyclical lows. Differentiation: APRA’s pending reform of the illiquidity premium should align with Solvency II, materially freeing capital and improving ROE without new risk. Underwriting: A $400–700m day-one capital release (~A$0.60–1.00/sh) plus a further ~$600m from asset re-mixing enables ~25–35% buyback potential. Valuation: Re-rating to 11.5× FY26E P/E with 30% share shrink implies ~50% total return; downside limited to ~15% at 8×. Risks: Delayed reform, watered-down APRA outcome, credit-spread blow-out, or renewed Apollo sell-down; mitigated by current 1.6× PCA and diversification into alternatives. View: A regulatory-driven capital-release story where policy convergence with global peers could unlock >A$1.5bn and catalyze a sharp re-rating.

Pitch Summary:
@MattJMcClintock argues that Lululemon’s guidance miss is more macro-driven than brand-driven, highlighting strong China comps, disciplined inventory, and expanding gross margins as evidence that underlying demand remains solid. He points to an innovation-heavy product cycle, including Daydrift and seasonal launches, as well as renewed marketing efforts that should reaccelerate momentum once traffic stabilizes. Although traffic softness persists, historical relationships between newness and sell-through suggest potential improvement later in the year. Overall, he views the brand as fundamentally strong despite the near-term guide.

BSD Analysis:
The global athletic apparel industry is in a digestion phase after years of excess demand pull-forward, disproportionately impacting traffic-sensitive premium brands. Lululemon’s competitive position remains differentiated through technical product credibility, female-led design authority, and pricing power evidenced by controlled markdowns. China performance reinforces brand heat in international markets where athletic and lifestyle convergence is still underpenetrated. The key near-term risk is that macro-driven traffic softness persists longer than expected, delaying revenue acceleration despite strong product. However, inventory health and margin resilience suggest the business is not structurally over-earning. Marketing reinvestment appears measured rather than defensive, preserving long-term brand equity. Valuation will hinge on confidence in a US reacceleration rather than China alone. If traffic normalizes and new franchises scale as prior cycles suggest, LULU should reassert itself as a category winner rather than a maturing brand in decline.

Actual Post Content:
$LULU 4Q24 Immediate Call Postmortem The guidance miss is of course cause for concern and the stock should deservingly be down. Yet don’t think its reflective of anything brand specific and they are large enough now that likely can no longer avoid feeling broader consumer pressures. Calvin called out a lot of innovation coming this year and it feels like the company course corrected early enough post Sun leaving, but have to admit not great look that all their excitement about upcoming product somehow couldn’t find its way into the revenue guide (Ike and Boss were on this in Q&A). Bulls can take some comfort in that the brand continues to win in China with comps sequentially accelerating to 27% cc from 24%. Stands in stark contrast to some of their peers. Clearly they are firmly entrenched in the “winner” bucket over there. Inventory came in lower than their guidance (up 9% vs. LDD guide) and gross margin was up partially due to lower markdowns. These are not the things you see with any challenged or declining relevance brand. Keep that in mind when bears are screaming “its so over” tomorrow. Calvin called out much more specific newness than Nike did, that’s for sure. Excited about this spring and later this year. Initial response to Daydrift very strong and selling out – they think it will become a new core franchise as consistent with past successful product launches. “Technical product with a wide range of use cases” – people really don’t understand this relatively unique positioning of $LULU. 'Lulu-Linen' - have seen the product before but never thought how awesome that name resonates. Sign me up for whatever they sell this summer. Consumers are responding to newness – trends sequentially improved last year as they added it. Problem right now is just traffic (blamed that on industrywide macro). Units per ticket and average order size both positive right now so when they get you in the door, the consumer responds. They are now back to historical levels of newness in the product mix. Expect modest US growth this year. NA up LSD-MSD with the US low end and Canada high end. 1Q “is not trending materially differently than 4Q”. The decline of newness was most pronounced in 2Q so 1Q is their most difficult compare this year. They wouldn’t blame weather – “control what we can control”. They continue to call out strength in their bags business. I am old enough to remember when the tough compares there was the primary bear thesis. Feels like Brooke at GS listened to the advice I gave her on marketing questions last quarter. Calvin said the word “unique” multiple times when describing their activations strategy. Energy and cadence stronger than they have done in a number of years. Playing offense right now as they wait for broader consumer traffic to come back. Lejuez got them to say they expect to spend 5% of sales on marketing this year but can flex if appropriate. *These are my unabridged quick thoughts and notes from the call. I try to get them out as soon as possible after the call ends. Please know there may be errors in this information as it hasn’t been reviewed. I may write more detailed thoughts later after fully digesting all information communicated.

URL: https://x.com/MattJMcClintock/status/1905376751334949064

Pitch Summary:
The author argues that Exor remains deeply undervalued, trading at ~€90 versus a reported NAV of €178.8, a ~50% discount. Exor realized €3bn from selling 4% of Ferrari and redeployed €1bn into a buyback, a highly accretive move given the NAV discount and Ferrari’s valuation. The majority shareholder, Giovanni Agnelli B.V., is participating with €570m, effectively using the tender as a liquidity event while reducing holding-level leverage, with Exor cancelling all repurchased shares. Portfolio income remains diversified, led by dividends from Stellantis, Philips, Ferrari, and CNH Industrial. Portfolio value movements highlight mixed operating conditions (pressure in luxury via Christian Louboutin) offset by strong gains in Welltec, infrastructure, media, and the Lingotto funds. Management costs remain tightly controlled, reinforcing capital discipline.

BSD Analysis:
European holding companies often trade at persistent NAV discounts, but Exor’s is unusually wide given asset quality, liquidity, and capital allocation track record. Its competitive position as a long-term owner with opportunistic trading capability was reinforced by the well-timed Ferrari stake reduction and immediate reinvestment into discounted equity. Concentration risk is real—Ferrari remains over 40% of NAV—but disciplined recycling mitigates single-asset dependence over time. The portfolio spans cyclical autos, healthcare, luxury, media, and private growth assets, smoothing cash flows while preserving upside optionality. The key risk is discount entrenchment: absent structural catalysts, holding company discounts can remain stubborn despite good execution. However, aggressive buybacks, insider participation, and consistent share cancellation directly attack that issue. Valuation already prices in conservative assumptions for several holdings, while upside comes from both NAV growth and discount narrowing. In this context, Exor offers a rare combination of high-quality assets, active capital management, and self-help tools at a generationally wide discount.

Actual Post Content:
Exor thread following 2024 annual results: -NAV at 178,8 € -share price: 90€ -discount to NAV: 49,6%. - 3 Billion € from the sell of 4% of Ferrari. 1 billion € in a new buyback program. Great move considering Ferrari valuation and discount to NAV on Exor. - Increased stake in 2025 in Philipps to 18,7%. - still owns 20% of Ferrari. - interesting to see that Giovanni Agnelli B.V (exor's majority shareholder) is participating for 570 M€ at the new buyback/tender offer. In effect it is a liquidity offer and the majority shareholder is reducing debt at its level. - Exor consistently cancels the shares they buyback. This is their very good approach. - when you look at the dividend Exor receives when you go from the biggest to the smallest contributor in 2025 we have 1/Stellantis (306 M€) 2/Philips (147 M€) 3/Ferrari (113 M€) 4/CNH (84 M€). - sure Ferrari represents 43,2% of the NAV at 31/12/2024 but capital allocation skills are historically good and we had a recent illustration of that with the opportunist sell of 4% of Ferrari. - Clarivate holding moved from othets to listed companies after Exor got a board seat. -Philips dividend can either be in cash or in shares. - Change in value in unlisted companies gives us interesting information: Luxury isn't easy with -125 M€ (-18,8%) for Christian Louboutin. Welltec is dingue great with a 50% increase in value. Institut Merieux increases by 5%. Via transportation increases by 11,2%. The Economist gets a +8,3% . - Lingotto funds did great with a + 28,6% increase in value. Helped especially by the public funds. - they have a small stake in Banijay group (like Vivendi). - it is great that they give us the management costs which are at 28 m€ and decreased by 1 M€. This amount is under control and isn't excessive. If other holdings could give us this information it would be great!

URL: https://x.com/FoxCastlehold/status/1905285793792373203

Pitch Summary:
TaskUs is a tech-focused BPO providing digital CX, trust & safety, and AI services, growing 17% y/y in Q4 and guiding to ~19% in Q1. Mix headwinds in 2023 (Meta’s offshoring pivot, Tesla autonomy shift) are now in the base, with Meta growth reaccelerating to +63% y/y in Q4. AI services (data labeling, red-teaming, LLM support) are inflecting as marquee customers scale, with management calling out “material” acceleration in 1H25. New logos (a “new social media” likely TikTok) and vertical expansion (healthcare—likely UNH—and financial services) broaden the revenue base. Headcount leading indicators (LinkedIn tracking) correlate tightly with revenue, supporting above-guide growth. While gross margin has compressed from hiring ahead of demand and FX/security noise, SG&A leverage and utilization should stabilize margins into 2026. Shares trade at ~5.5x 2025E EBITDA and ~7–8x TEV/EBIT, a steep discount to a double-digit grower. A 2026 framework of ~$284m adj. EBITDA at a 10x multiple implies ~$30/sh, ~120% upside versus ~$13–14. Blackstone owns ~51% and is past a typical PE hold window, creating credible strategic/exit optionality. AI isn’t disintermediating near-term CX; accuracy, liability, cost, and human-preference frictions keep humans in-the-loop, favoring scaled vendors like TASK.

BSD Analysis:
TASK is a scaled, tech-native outsourcer across Digital CX, Trust & Safety (content moderation), and AI services (labeling, evaluation, red-teaming) with ~60k employees and concentrated exposure to large internet platforms. Set-up: 2023 softness (tech austerity, Meta geography mix) fostered a bearish “AI will kill BPOs” narrative just as demand and headcount inflected in late-2024; shares now embed ~5–6x EBITDA. Differentiation: Deep domain in high-velocity internet work, T&S operations maturity, and live AI eval pipelines position TASK as a preferred in-the-loop partner for hyperscalers and frontier-model labs. Valuation: At ~7.3x/6.1x 2025/26 TEV/EBIT and ~11x/9x P/FCF, a re-rate toward ~10x 2026E EBITDA on ~$284m supports ~$30/sh; upside can compound if growth exceeds conservative guide or if Blackstone catalyzes a sale. Risks: Pricing pressure and margin drag from proactive hiring; client concentration (Meta); FX and country risk; AI substitution faster than expected; security incidents. View: With growth re-accelerating, margin stabilization ahead, and credible M&A optionality, risk/reward is favorable and the multiple too low for the trajectory.

Pitch Summary:
Brookfield Business Partners (BBU) is Brookfield’s public private-equity vehicle, effectively a listed holdco owning operating companies across business services, infrastructure services, and industrials. Shares trade at a steep discount to management’s NAV estimate (they cite 50%+), widened since 2022 with higher rates and holdco aversion. Management has initiated a ~$250m buyback (~5% of mkt cap) and is “in the market daily,” aiming to close the gap. Historical invested capital (~$9B) exceeds today’s TEV (~$8B), offering downside protection while Brookfield targets high-teens NAV CAGR. The portfolio has produced marquee wins (e.g., GrafTech, Westinghouse) and continues to emphasize “heavy-lift” operational turnarounds. Near-term monetizations were slower than hoped (e.g., Clarios IPO deferred in favor of a dividend recap), but cash returns still flow to BBU. If the discount persists, parent Brookfield Corp (BN) could credibly buy in minorities, creating a second path to value realization. On author math, current NAV per unit is in the low-$40s; applying a 25% discount implies ~$32 fair value. With rates stabilizing and repurchases compounding, the 2–3 year setup looks asymmetric.

BSD Analysis:
BBU acquires and operates essential-service and industrial businesses globally, paying Brookfield a 1.25% base fee and performance-linked incentive over a $31.53/unit threshold. Set-up: Units trade far below NAV (management says 50%+), partly due to rate-driven multiple compression, low liquidity, and disappointment around Clarios’ non-IPO path. Differentiation: Brookfield’s PE platform leans into complex, underloved assets where operational uplift drives most of the value creation; past exits (GrafTech, Westinghouse) validate the playbook. Valuation: TEV (~$8B) vs invested capital (~$9B) plus buybacks supports downside; author pegs NAV in low-$40s and targets ~$32 on a 25% discount (still conservative vs history). Risks: ProBulled holdco discount, higher rates, slow realizations, or a low-ball parent buy-in; fee drag persists until the discount narrows. View: High-quality sponsor, active repurchases, and optionality for a parent take-out create favorable skew over 2–3 years.

Pitch Summary:
Amkor is a leading outsourced assembly and test (OSAT) provider whose story is shifting as “advanced packaging” becomes mission-critical to semiconductor performance. The author argues—based solely on public signals—that Amkor is in an active sale process likely to clear at ~$28–$30 per share (~50% premium). Telltales include bylaw amendments (tightened indemnification; exclusive-forum/alternative-forum consent), first-time public posting of the insider-trading policy, a sudden halt in routine insider selling, and appointment of an ex-M&A banker (John Liu) to the board. Additional “weird but consistent” signals: CEO/CFO skipped a key sell-side conference (an operations EVP presented instead) and the controlling Kim family has been aggressively reorganizing holdings (GRATs/Kim Capital Partners) after the patriarch’s board exit. Strategically, Amkor is the only U.S. OSAT and is building a CHIPS-supported advanced-packaging fab in Arizona—assets that could fetch a premium from a strategic consolidator (ASE et al.) seeking U.S. footprint and scale. Even stand-alone, the stock screens inexpensive (EV/S ~0.7× vs ASE ~1.4×) with EPS poised to recover ($1.50 in 2025, ~$2.00 in 2026 on author’s math). Industry structure is improving as advanced packaging (2.5D/3D, SiP, CoWoS-like flows) requires heavy capex/IP, reducing pure price competition. Governance supports an exit: no Kim family executives remain, the chair lacks semi/OSAT background, and there is no clear succession plan for a 50%+ control block. A transaction would also rationalize capacity and likely deliver sizable synergies for a buyer, justifying the premium. Base case: deal at ~$30; backstop: stand-alone rerate toward ~$20 as cycle/CHIPS tailwinds show through.

BSD Analysis:
Amkor provides semiconductor packaging and final test across mobile, auto/EV, HPC/AI and consumer end-markets, with a growing focus on advanced packaging that pushes performance without strict Moore’s Law scaling. Set-up: Shares have de-rated on cyclical end-markets, while multiple public cues (bylaw changes, forum selection, insider-sale drought, M&A-savvy director addition, GRAT/estate activity) suggest a late-stage sale process. Differentiation: Only U.S. OSAT with a CHIPS-funded Arizona advanced-packaging site; strategic scarcity plus U.S. domestic positioning add value to consolidators seeking geopolitically resilient supply chains. Valuation: Trades near trough relative EV/S vs ASE despite expected EPS recovery; author pegs take-out at $28–$30 (~50% premium) with synergy logic and improving industry structure as support. Risks: Process may stall; bidder/regulatory risk (CFIUS/antitrust); CHIPS funding timing; cyclicality (smartphone/PC/EV); partial leak causing run-up then disappointment. View: Asymmetric—credible M&A tells with strategic scarcity provide upside to ~$30; even without a deal, improving cycle/CHIPS visibility and relative discount argue for a re-rate.

Pitch Summary:
Accounting and disclosure irregularities; manipulated profits and cash flow; limited proprietary software.

BSD Analysis:
Kyndryl, spun out of IBM, operates one of the largest IT infrastructure services platforms. The short thesis focuses on structurally declining legacy outsourcing contracts, thin margins, and execution risk in its transformation strategy. With high leverage and exposure to long-term contracts that renew at lower pricing, operating leverage cuts both ways. Investors should watch for progress in cloud migration partnerships (Azure, AWS, Google), but skepticism remains about whether KD can pivot fast enough to stem secular declines.

Pitch Summary:
Low incrementality; Collecting/structuring user IDs violating key platforms' Terms of Service; significant risk of being deplatformed; Easily replicable techniques; Significant e-commerce client churn threatening future growth. Update 5/8/25 - The CEO denied the use of persistent identifiers that violate users' privacy and partner platforms' terms of service, but a third-party investigator's findings contradict this claim.

BSD Analysis:
AppLovin’s dependence on mobile gaming installs and adtech positioning creates cyclicality. Privacy shifts (ATT) have pressured monetization. Shorts argue valuation discounts competitive threats from Unity and legacy gaming ad networks, while debt-financed growth elevates leverage.

Pitch Summary:
The author argues that NTG Clarity Networks ($NCI.V) delivered an exceptional 2025 outlook, guiding to 35%+ revenue growth following nearly 100% YoY growth in 2024. Backlog has expanded to $105m, with ~$80m now tied to three-year contracts, materially improving revenue visibility versus the company’s historical one-year deal mix. Despite this growth and secular exposure to Saudi Vision 2030 spending, the stock trades at roughly 6× guided EBITDA. Near-term margin guidance disappointed, which the author attributes to temporary cost ramping tied to onboarding and deploying staff for newly awarded Saudi contracts, pressuring Q4 and early Q1 margins. Management is viewed as conservative, with expectations that margins normalize toward ~20% EBITDA by Q2/H2. At current prices, the stock screens as ~7.5× 2025 EPS and ~5× 2026 EPS, which the author views as disconnected from fundamentals.

BSD Analysis:
The Middle East IT services market is structurally supported by long-cycle government digitization programs, with Saudi Vision 2030 providing unusually strong demand visibility. NTG’s competitive position has improved meaningfully as it shifts toward larger, multi-year contracts, reducing volatility and enhancing operating leverage. The business model is execution-heavy, requiring upfront hiring and mobilization, which explains near-term margin compression but also creates barriers to entry for smaller competitors. Key risks include delivery execution, client concentration, and geopolitical sensitivity inherent in the region. However, backlog quality and duration materially de-risk revenue forecasts relative to prior cycles. Valuation appears to price margins as structurally lower rather than temporarily depressed. If margins normalize as contracts mature, earnings power could inflect sharply. In that scenario, the current multiple understates both growth durability and mid-cycle profitability, setting up a potential re-rating as execution catches up with backlog scale.

Actual Post Content:
$NCI.V guides for 2025. Pretty incredible set of numbers, after growing near 100% YoY in 2024 they're guiding to 35%+ revenue growth in 2025. Backlog now a whopping $105M, and revenue quality and visibility keeps improving with $80M of that backlog from 3 year contracts, a significant change from the 1 year contracts they used to get in the past. Stock is 6x EBITDA off their guide for a 35%+ topline grower, insulated from macro with tons of secular growth driven by Saudi 2030. Their margin guide is a bit lower than what Id had thought, by maybe 1%. Most likely has to do with the investments they're making to ramp on the huge contract wins they were awarded. As we know Q4 will be sort of a 5% EBITDA margin quarter (essentially already released from the March 25 presentation) as they train all the employees they'll send to Saudi to fulfill the new contracts. Q1 will be better likely in the low teens and back to normal in Q2. I think the margin guide is likely management being conservative. Overall super solid, tough to find companies growing 35% at 6x EBITDA with secular tailwinds and a significant portion of recurring revenue. I guess it's fuck $NCI.V up the ass day. Margins clearly what is bugging the market. Likely the Q4 cost ramp from the big contracts bleeding a bit more into Q1 than expected. I do think in Q2/H2 you'll see them hit 20% EBITDA margins. I think the stock is 7.5x 25 EPS and 5x 26 EPS here.

URL: https://x.com/everyonehatesp1/status/1904874100377395695

Pitch Summary:
The author argues that Rinko Corporation (TYO:9355) is likely a value trap despite trading at a deep discount to book value. The company owns the Rinko Wharf in Niigata—the only privately owned port in Japan—with roughly ¥20bn of assets tied up in the port business, which consistently generates small losses. While other segments (real estate and a hotel) are profitable, they are not large enough to justify the asset base. The only potentially interesting angle is that Kawasaki Kisen Kaisha owns ~25% of Rinko and uses the port, creating optionality around a strategic buyout or asset repurposing. Absent a catalyst to improve port profitability, unlock asset value, or repurpose the land, the author views the stock as cheap but unexciting and not worth adding to.

BSD Analysis:
Port ownership in Japan is structurally challenging, with regulated pricing, high fixed costs, and limited volume growth outside specialized energy or logistics use cases. Rinko’s competitive position is weak despite asset scarcity: owning a private port has little value if throughput and utilization remain subscale. Persistent losses in the core port segment suggest either structural demand limitations in Niigata or inefficient asset utilization, undermining the headline balance-sheet value. The presence of a strategic shareholder provides theoretical optionality, but no evidence of capital allocation intent. The key risk is capital being trapped indefinitely in low-return assets, which justifies a chronic valuation discount. Upside would require a step-change—such as LNG infrastructure, logistics redevelopment, or a take-private transaction—but none appear imminent. In absence of productivity gains, asset value alone is insufficient. This is a classic “cheap-for-a-reason” situation where opportunity cost dominates, particularly in a market with many higher-quality Japanese value dislocations.

Actual Post Content:
Rinko Corp (TYO 9355) owns the Rinko Wharf, in Niigata. It's the only privately owned port in Japan. This segment has ¥20 billion in assets (mostly the port land) and reports a small loss every year. Other segments profitable. P/E: 13 Price: ¥1,850 BVPS: ¥7,030 MCAP: ¥4.8 billion ($32m) This is likely a value trap as the core port biz has tons of assets but loses money. They own RE and a hotel which is profitable. The only good part of the story is Kawasaki Kisen Kaisha(¥1.4T mcap, $9.2 billion) owns ~25%. Maybe they just buy it as they use the port. Maybe there's an LNG story in there somewhere. it's too small, too illiquid, and not great on profits. It's cheap on asset value, but we need some productivity on those assets. On the flip side, if they can make the port profitable could be big upside. Prob a value trap. Owned a tiny position before doing any reading on it. And after some research, I'm not adding any more. If the 20b in port assets can't generate any profit, they're likely over valued on the balance sheet or Rinko just sucks at operating it. Cheap alone isn't that interesting. You need the assets to be semi productive at least! They are largely profitable though except 09 and covid. Way better bets out there imo On the flip side a name like this is imo a better bet than most tiny nanocaps in U.S. markets which are usually pretty awful. I'm just not excited about it in JP as there are many better bets.

URL: https://x.com/AltayCapital/status/1905053087229960265

Pitch Summary:
Irish Continental Group (ICGC) is a leading Irish ferry and port operator offering essential freight and passenger transport links between Ireland, the UK, and Continental Europe. The market misprices it as a cyclical shipping company when it’s effectively a high-margin infrastructure business with inflation-linked revenues and real-asset backing. Its two divisions — Ferries (Irish Ferries) and Container & Terminals (Eucon and Dublin/Belfast ports) — generate over €130m EBITDA with 75%+ FCF conversion and modest cyclicality. Key upside drivers include Brexit-related duty-free windfalls (adding €10–15m EBITDA), a full recovery in tourism/passenger volumes post-COVID, and the now-maturing Dover–Calais expansion turning from drag to driver. Freight volumes hit records in 2024 (+6% YoY) as ICGC captured market share on core Irish Sea routes and stabilized pricing through a rational alliance with P&O. Management, led by owner-operator CEO Eamonn Rothwell (30+ years, ~19% stake), has returned €570m via dividends/buybacks and continues to allocate capital like a private equity owner. Balance sheet leverage is under 1x, leaving flexibility for accelerated buybacks or a strategic transaction. At ~€5/sh and €700m market cap, ICGC trades at ~8x FCF and ~6.5x EV/EBITDA — a steep discount to DFDS and port peers trading 10–12x. Normalized EBITDA of €150m implies ~€7.50/sh fair value (50% upside), with Buller-term rerating potential if investors view it as quasi-infrastructure. Asset replacement value, dividend yield (~4%), and downside protection from tangible ships and ports offer strong risk/reward.

BSD Analysis:
ICGC operates ferries, ports, and container shipping under the Irish Ferries and Eucon brands, forming a critical transport network connecting Ireland to the UK and Europe. Set-up: Despite record EBITDA (€133.5m) and FCF (~€100m), the stock trades near 8x normalized FCF due to small-cap and “ferry operator” stigma; investors overlook duty-free tailwinds, recovering passenger traffic, and underappreciated freight resilience. Differentiation: ICGC’s moat rests on scarce port access, a duopoly on Irish Sea crossings, and integrated ferry-container infrastructure enabling end-to-end logistics — all backed by inflation-linked pricing and Bull-term concessions. Valuation: 2024 EBITDA €133m vs EV €860m = ~6.5x; even modest re-rating to 8x yields €7.5–8/share; replacement-cost NAV of ships and ports alone supports today’s EV, implying limited downside. Risks: UK/EU recession reducing freight and travel volumes, fuel price spikes or carbon taxes, management succession as Rothwell nears retirement, and potential short-term competition on Dover–Calais. View: A rare inflation-protected infrastructure-like compounder disguised as a ferry line; owner-operator governance, real assets, and growing cash flows create asymmetric upside with robust downside protection.

Pitch Summary:
Rayonier Advanced Materials is a leading producer of cellulose specialties (CS) with oligopolistic structure, high switching costs, and rising pricing power after GP Foley’s exit. The author argues the market is mislabeling RYAM as a cyclical, commodity paper/pulp name while the value driver is High Purity Cellulose with 90%+ global utilization and bespoke customer qualifications. 2025 looks messy (plant maintenance at all three HPC sites, modest CS volumes, tariff uncertainty, Jesup fire carryover, and a delayed Fernandina bioethanol permit), but liquidity is solid and maturities are pushed out. Management guides to $37–57m recurring FCF in 2025 (normalized closer to ~$50–70m after timing/one-offs), implying a double-digit equity FCF yield on the current ~$375m market cap. From 2026, self-help and mix drive a step-up: strategic capex yields ~$21m cost saves, biomaterials contribute $8–10m incremental, and pricing adds ~$10–12m, taking EBITDA to ~$254–278m. Assuming Temiscaming (paperboard/high-yield pulp) sells for ~$150m and proceeds reduce debt, 2026 FCF is modeled at ~$113–137m (30–37% to equity) with net leverage ~2.0x. On a conservative 7x EBITDA, equity value screens around $19–22/share in 2026, ~3.5x the stock. A Buller runway exists via biomaterials (BioNova JV, Tartas 2G ethanol offtake, lignosulfonates/tall-oil; Fernandina ethanol next) and optionality in ethers/nitrocellulose, taking 2029 EBITDA to ~$379–443m. On 8x EBITDA, 2029 equity value could be ~$41–50/share (7–10x). Risks include tariff outcomes, execution on disposals, maintenance reliability, and Europe macro, but the author sees multiple, near-dated catalysts to close the gap.

BSD Analysis:
RYAM’s core is High Purity Cellulose (cellulose specialties, fluff, limited viscose) produced at Jesup, Fernandina, and Tartas; Temiscaming houses paperboard and high-yield pulp, both for sale. Set-up: Shares are down despite balance-sheet repair, price increases, and external validation of biomaterials; investors focus on near-term noise (maintenance, tariffs, Jesup fire, permit delay) and miss structural pricing power and a multi-year FCF inflection. Differentiation: CS products are spec-driven with Bull qualifications, high switching costs, few global competitors (Borregaard/Bracell), and rising NA monopoly niches (filtration, tire cord, nitrocellulose) post Foley; brownfield capacity economics are punishing without sustainably higher margins. Valuation: At ~$5.70, equity implies a 2026 FCF yield to equity of ~30–37% under the author’s bridge; 7x 2026E EBITDA supports ~$19–22/sh and 8x 2029E supports ~$41–50/sh, even before potential refinancing savings and insurance proceeds. Risks: Adverse tariff regimes or a delayed/low-price Temiscaming sale, extended outages or cost inflation, European industrial softness (ethers), and permitting setbacks in bioethanol. View: With pricing, cost-out, biomaterials growth, and a likely Temiscaming exit, RYAM screens as a misunderstood, cash-compounder pivoting from “pulp” optics to specialty biomaterials—and offers asymmetric upside over 12–36 months.

Pitch Summary:
Marqeta is a card-issuing and embedded-payments platform whose stock is down ~90% from IPO but now sits on ~$1.1B net cash and an active buyback, creating a skewed setup. The author argues multiple near-term catalysts: a new CEO, aggressive cost cuts (esp. comp/SBC and professional services), and continued repurchases equal to ~15–20% of shares outstanding. Growth has re-accelerated (FY25 guide +16–18% revenue; gross profit +14–16%) as headwinds from the 2023 Block/Cash App repricing have been lapped and non-Block TPV outpaces Block. Mix shift to “Managed by Marqeta” and to credit/BNPL should raise take rates, while European expansion (TransactPay EMI license, Spendesk) opens higher-value programs. Management guides to GAAP profitability “at points” in 2026, implying opex discipline after years of dilution and drift. Concentration risk is improving (Block ~46% of revs in MRQ vs >70% in 2023) and EU TPV grew ~90% y/y, supporting diversification into 2027–28 renegotiations. With EV ≈ $1.0B (at ~$4–4.5/sh), shares trade ~1.6x FY25 sales and ~2.5x FY25 gross profit, cheaper than most fintech comps. Base-case DCF and 2028 EBITDA math suggest $9–12/share fair value (2–3x MOIC in 2–3 years) without crediting upside from sustained buybacks. Risks include renewed bank-partner scrutiny delaying launches, a softer consumer/BNPL cycle, and a tough 2028 Block renewal, but cash, buybacks, and opex levers cushion downside. Optionality includes an acquisition before/after the CEO hire if execution lags.

BSD Analysis:
Marqeta provides modern card issuing, processing, and program management (PxM vs higher-margin MxM) to fintechs and enterprises, monetizing via interchange split, network incentives, and platform fees. Set-up: Sentiment cratered after the 2023 Block repricing and 2024 bank-partner delays; today the contract is fully lapped, non-Block TPV is comping faster, and Europe is opening post-TransactPay—while a CEO search and an ample buyback are in motion. Differentiation: Depth in real-time funding controls, developer tooling, and risk/fraud plus network relationships (Visa/Mastercard incentive tiers) make MQ a credible scaled alternative to in-house builds/BaaS point solutions. Valuation: ~1.6x FY25 EV/S and ~2.5x EV/GP imply very low expectations; if take rate/mix and opex discipline drive EBITDA to low-nine figures by 2028, 18–20x EBITDA or ~3x GP supports $9–12/share. Risks: 2028 Block renewal could pressure take rates; regulatory friction at sponsor banks could persist; SBC culture and execution discipline hinge on the new CEO; macro-sensitive spend (BNPL/gig) could wobble. View: With cash covering ~60% of market cap, accelerating GP, and self-help (buybacks + costs), MQ offers a favorable asymmetry into multiple catalysts; execution is key but the bar is low.

Pitch Summary:
Solesence has shown impressive growth since launching its proprietary zinc oxide formula, with sales reaching over $40M in 2024. Despite a significant rally, the stock is still undervalued at ~14x 2025e EPS. The company is poised for further growth with potential uplisting and continued expansion in the beauty market, offering a potential upside of ~115% if it trades closer to 30x earnings.

BSD Analysis:
Solesence's strategic shift to fully formulated cosmetics has resulted in higher margins and steadier sales growth. The company's proprietary zinc oxide formulas are highly regarded, and their largest customer, Colorescience, has significantly contributed to revenue growth, especially after going viral on TikTok. Despite past financial and legal challenges, Solesence has returned to profitability and is expected to continue its growth trajectory. The company's focus on expanding into masstige brands and the rising popularity of SPF makeup products are additional growth drivers. Potential risks include customer concentration and industry shifts, but the company's strong market position and insider confidence mitigate these concerns.

Pitch Summary:
Sales are lagging with declining market share; Costco is ending its contract, potential huge cost in revenue; Significant supply chain issues, failed diversification, and insider sell-offs

BSD Analysis:
The Vita Coco Company has carved a niche in coconut water but trades at multiples implying durable growth. Bear cases highlight category saturation, increasing competition from private labels, and rising input costs tied to coconut supply volatility. While international expansion offers some upside, margin compression from commodity inflation and promotional intensity could erode returns. As growth normalizes, re-rating toward broader beverage peers could drive downside.

Pitch Summary:
@AlphaSenseInc summarizes a former competitor’s view that Palantir’s dominance is rooted in deep U.S. government integration and unmatched ability to deliver real-time, field-ready AI in highly secure environments. The company benefits from enormous barriers to entry tied to certifications, mission-critical reliability, and decades of operational trust. While major tech firms compete broadly in AI, none match PLTR’s specialization in national security analytics, which forms a durable moat. Over the next decade the expert expects Palantir to evolve into a major platform company by leveraging government-driven credibility to scale commercial verticals. The pitch is fundamentally bullish and underscores PLTR’s unique strategic positioning.

BSD Analysis:
Palantir’s moat is structurally tied to national security workloads, which few competitors are equipped to pursue due to security clearances, procurement friction, and operational risk. This creates sticky, long-duration revenue and defensibility. The commercial market is more contested, and PLTR must demonstrate that its product-led onboarding approach can scale sustainably. AI commoditization remains a threat, but PLTR’s differentiation lies not in raw model capability but in orchestrating real-time decisions in sensitive contexts. Budget cycles and political risk introduce volatility, yet Palantir’s entrenched nature and increasing alignment with defense modernization provide long-term strategic tailwinds.

Actual Post Content:
Interview with a former $PLTR competitor explaining how deep government ties and real-time AI capabilities build a lasting competitive edge: - The expert emphasized that $PLTR's core competitive advantage lies in its deep entrenchment with government contracts and its ability to operate in highly secure, high-stakes environments. Unlike many AI firms that are cloud-native and broadly focused, $PLTR delivers real-time, on-the-ground AI capabilities that can be deployed in the field, like with TITAN missile systems, rather than just traditional business intelligence or risk modeling. - What makes $PLTR particularly sticky in the defense space is the extremely high barrier to entry. Gaining access to work with the U.S. government requires a complex set of certifications, which is both time-consuming and capital-intensive. - The expert acknowledged that AI capabilities are becoming commoditized, and competitors like $MSFT, $AMZN, OpenAI, and $GOOGL are formidable; however, the expert emphasized that $PLTR's depth in high-security, mission-critical government applications remains unmatched. Compliance alone isn’t enough to win those contracts. You also need the ability to drive real-time insights and decisions in the field, something $PLTR has already proven at scale. - Looking five to ten years ahead, the expert sees $PLTR evolving into a platform on par with major tech players, such as $MSFT or $AAPL, in its niche. While broader competition will intensify, especially in commercial sectors like healthcare and finance, the expert believes $PLTR's dominance in national security and government analytics will continue to serve as a durable moat. - From experience working at a $PLTR competitor, the expert noted that many AI companies try to be “everything to everyone,” chasing broad adoption. $PLTR's strategic approach, which starts with high-value government contracts, proves value, and then expands, stands in sharp contrast to competitors. The expert linked this to “capturing the capital first before branching out,” a method that builds credibility and operational momentum.

URL: https://x.com/AlphaSenseInc/status/1904546959467348448